CLINICAL_TRIALS
trial_result
· 2009-03-06
Clinical Trial Update: Esomeprazole in PPI Failures - IMPROVE [Phase 4]
Summary
Phase 4 IMPROVE trial evaluating esomeprazole in patients with gastroesophageal reflux disease who failed prior PPI therapy has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED